A PYMNTS Company

US: Pharma merger breezes through antitrust clearance

By  |  September 15, 2013

Pharmaceutical companies Cubist and Optimer announced Friday US antitrust regulators have effective cleared their merger following the expiration of the merger waiting period. As a result, Cubist Pharmaceuticals will acquire all outstanding common Optimer stock, according to reports.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Despite regulatory approval, the transaction remains subject to shareholder clearance as well.

    Full Content: RTT News

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.